• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular understanding of CD26-mediated immune regulatory mechanism and development of novel molecular targeted therapy for the treatment of refractory autoimmune diseases

Research Project

Project/Area Number 16H05345
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Collagenous pathology/Allergology
Research InstitutionJuntendo University

Principal Investigator

Morimoto Chikao  順天堂大学, 医学(系)研究科(研究院), 特任教授 (30119028)

Co-Investigator(Kenkyū-buntansha) 岩田 哲史  順天堂大学, 医学(系)研究科(研究院), 非常勤講師 (00396871)
大沼 圭  順天堂大学, 医学(系)研究科(研究院), 准教授 (10396872)
波多野 良  順天堂大学, 医学(系)研究科(研究院), 特任助教 (30638789)
Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2018: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2017: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥7,410,000 (Direct Cost: ¥5,700,000、Indirect Cost: ¥1,710,000)
KeywordsCD26/DPPIV / T細胞 / 共刺激分子 / IL-10 / ヒト免疫 / 免疫チェックポイント分子 / 全身性エリテマトーデス / 悪性胸膜中皮腫 / 自己免疫疾患 / 免疫制御 / 腫瘍免疫 / SLE / CD26 / LAG-3 / 臨床免疫学 / BTLA / 慢性GVHD / 移植免疫学 / 血液免疫学 / 小児血液学
Outline of Final Research Achievements

CD26 is a T cell costimulatory molecule, and plays an important role in the human immune system. We have recently shown that CD26 not only functions in T cell activation, but also may serve as an immune regulator. From our extensive examination, we found that the expression levels of IL-10, LAG3 and BTLA in human CD4 T cells, and those of BTLA in CD8 T cells were markedly enhanced following CD26 costimulation, as compared with CD28 costimulation.
However, CD26+LAG3+ or BTLA+ CD4 T cells or CD26+BTLA+ CD8 T cells were hardly found in the peripheral blood of SLE patients or healthy adult volunteers. In contrast, the percentage of immune checkpoint molecules-expressing T cells was prominently increased in the pleural fluid of malignant pleural mesothelioma patients, and we could find CD26+LAG3+ or CD26+BTLA+ T cell subsets in the pleural fluid. The molecular mechanisms how the expression of LAG3 or BTLA is induced following CD26 costimulation are needed to be investigated in the future.

Academic Significance and Societal Importance of the Research Achievements

CD26分子はマウスT細胞では共刺激分子として機能せず、ヒト免疫において重要な分子である。免疫応答の負の制御メカニズムの解明は、自己免疫疾患の発症・悪化の根幹をなす問題であり、また、近年腫瘍免疫の分野においても、免疫応答を負に制御する免疫チェックポイント分子を阻害する免疫チェックポイント阻害薬は新たな治療薬として非常に注目されている。
さらに申請者らが開発したヒト化CD26抗体は、悪性胸膜中皮腫に対する第I/II相臨床試験を実施しているところであり、CD26抗体の新たな抗腫瘍作用メカニズムの解明にもつながることが期待される。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Annual Research Report
  • 2016 Annual Research Report
  • Research Products

    (52 results)

All 2019 2018 2017 2016 Other

All Journal Article (23 results) (of which Int'l Joint Research: 14 results,  Peer Reviewed: 23 results,  Open Access: 15 results,  Acknowledgement Compliant: 3 results) Presentation (22 results) (of which Int'l Joint Research: 4 results,  Invited: 1 results) Book (3 results) Remarks (1 results) Patent(Industrial Property Rights) (3 results)

  • [Journal Article] Biological effects of IL-26 on T cell-mediated skin inflammation, including psoriasis.2019

    • Author(s)
      Itoh T, Hatano R, Komiya E, Otsuka H, Narita Y, Aune TM, Dang NH, Matsuoka S, Naito H, Tominaga M, Takamori K, Morimoto C, Ohnuma K.
    • Journal Title

      J Invest Dermatol

      Volume: 139 Issue: 4 Pages: 878-889

    • DOI

      10.1016/j.jid.2018.09.037

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapy.2019

    • Author(s)
      Ohnuma K, Hatano R, Dang NH, Morimoto C.
    • Journal Title

      Mod Rheumatol

      Volume: 印刷中 Issue: 5 Pages: 721-732

    • DOI

      10.1080/14397595.2018.1532559

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.2018

    • Author(s)
      Okamoto T, Yamazaki H, Hatano R, Yamada T, Kaneko Y, Xu CW, Dang NH, Ohnuma K, Morimoto C.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 504 Issue: 2 Pages: 491-498

    • DOI

      10.1016/j.bbrc.2018.08.193

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma2018

    • Author(s)
      Hiroko Nishida, Mutsumi Hayashi, Chikao Morimoto, Michiie Sakamoto, Taketo Yamada
    • Journal Title

      Blood Cancer Journal

      Volume: 8(99) Issue: 11 Pages: 1-17

    • DOI

      10.1038/s41408-018-0127-y

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Effects of repetitive transcranial magnetic stimulation on ER stress-related genes and glutamate, y-aminobutyric acid and glycine transporter genes in mouse brain.2018

    • Author(s)
      Ikeda T, Kobayashi S, Morimoto C
    • Journal Title

      Biochem Biophys Rep

      Volume: 17 Pages: 10-16

    • DOI

      10.1016/j.bbrep.2018.10.015

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Gene expression microarray data from mouse CBS treated with rTMS for 30 days, mouse cerebrum and CBS treated with rTMS for 40 days2018

    • Author(s)
      Ikeda T, Kobayashi S, Morimoto C.
    • Journal Title

      Data Brief

      Volume: 17 Pages: 1078-1081

    • DOI

      10.1016/j.dib.2018.01.079

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target in selected immune disorders and cancers2018

    • Author(s)
      Ohnuma K, Hatano R, Komiya E, Otsuka H, Itoh T, Iwao N, Kaneko Y, Yamada T, Dang NH, Morimoto C
    • Journal Title

      Front Biosci

      Volume: 印刷中

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Caveolin-1, a binding protein of CD26, is essential for the anti-inflammatory effects of dipeptidyl peptidase-4 inhibitors on human and mouse macrophages2018

    • Author(s)
      Hiromura Munenori、Nohtomi Kyoko、Mori Yusaku、Kataoka Hideo、Sugano Marika、Ohnuma Kei、Kuwata Hirotaka、Hirano Tsutomu
    • Journal Title

      Biochemical and Biophysical Research Communications

      Volume: 495 Issue: 1 Pages: 223-229

    • DOI

      10.1016/j.bbrc.2017.11.016

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers2017

    • Author(s)
      Angevin, E. Isambert, N. Trillet-Lenoir, V. You, B. Alexandre, J. Zalcman, G. Vielh, P. Farace, F. Valleix, F. Podoll, T. Kuramochi, Y. Miyashita, I. Hosono, O. Dang, N. H. Ohnuma, K. Yamada, T. Kaneko, Y. Morimoto, C.
    • Journal Title

      Br J Cancer

      Volume: 印刷中 Issue: 9 Pages: 1-9

    • DOI

      10.1038/bjc.2017.62

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus2017

    • Author(s)
      Komiya, E. Hatano, R. Otsuka, H. Itoh, T. Yamazaki, H. Yamada, T. Dang, N. H. Tominaga, M. Suga, Y. Kimura, U. Takamori, K. Morimoto, C. Ohnuma, K.
    • Journal Title

      J Dermatol Sci

      Volume: 印刷中 Issue: 3 Pages: 212-221

    • DOI

      10.1016/j.jdermsci.2017.03.005

    • Related Report
      2017 Annual Research Report 2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] Identification of senescent cell surface targetable protein DDP4.2017

    • Author(s)
      71.Kim KM, Noh JH, Bodogai M, Martindale JL, Yang X, Indig FE, Basu SK, Ohnuma K, Morimoto C, Johnson PF, Biragyn A, Abdelmohsen K, Gorospe M.
    • Journal Title

      Genes Dev

      Volume: 31 Issue: 15 Pages: 1529-1534

    • DOI

      10.1101/gad.302570.117

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Gene expression microarray data from mouse cerebrum treated with rTMS for 30 days.2017

    • Author(s)
      Ikeda T, Kobayashi S, Morimoto C.
    • Journal Title

      Data Brief.

      Volume: 15 Pages: 948-969

    • DOI

      10.1016/j.dib.2017.10.034

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Current and Emerging Therapy for Malignant Pleural Mesothelioma: Focus on CD26/Dipeptidyl Peptidase IV as a Therapeutic Target.2017

    • Author(s)
      Doonan BP, Ohnuma K, Dang LH, Morimoto C, Dang NH.
    • Journal Title

      Current Cancer Therapy Reviews.

      Volume: 13 Pages: 1-13

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] First-in-Human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers2017

    • Author(s)
      Angevin E, Isambert N, Trillet-Lenoir V, You B, Alexandre J, Zalcman G, Vielh P, Farace F, Valleix F, Podoll T, Kuramochi Y, Miyashita I, Hosono O, Dang NH, Ohnuma K, Yamada T, Kaneko Y, Morimoto C
    • Journal Title

      Br.J.Cancer

      Volume: 62 Pages: 1-9

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Role of IL-26+CD26+CD4 T Cells in Pulmonary Chronic Graft-Versus-Host Disease and Treatment with Caveolin-1-Ig Fc Conjugate2016

    • Author(s)
      Ohnuma, K. Hatano, R. Itoh, T. Iwao, N. Dang, N. H. Morimoto, C.
    • Journal Title

      Crit Rev Immunol

      Volume: 36 Issue: 3 Pages: 239-267

    • DOI

      10.1615/critrevimmunol.2016018772

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] Identification of Nedd9 as a TGF-β-Smad2/3 target gene involved in RANKL-Induced osteoclastogenesis by comprehensive analysis2016

    • Author(s)
      Omata Y, Nakamura S, Koyama T, Yasui T, Hirose J, Izawa N, Matsumoto T, Imai Y, Seo S, Kurokawa M, Tsutsumi S, Kadono Y, Morimoto C, Aburatani H, Miyamoto T, Tanaka S.
    • Journal Title

      PLoS One.

      Volume: 11 Issue: 6 Pages: e0157992-e0157992

    • DOI

      10.1371/journal.pone.0157992

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Establishment of anti-mesothelioma monoclonal antibodies2016

    • Author(s)
      Mizutani N, Abe M, Matsuoka S, Kajino K, Wakiya M, Ohtsuji N, Hatano R, Morimoto C, Hino O
    • Journal Title

      BMC Res Notes

      Volume: 9 Issue: 1 Pages: 324-324

    • DOI

      10.1186/s13104-016-2128-x

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Transforming growth factor-β-induced CUX1 isoforms are associated with fibrosis in systemic sclerosis lung fibroblast2016

    • Author(s)
      Ikeda T, Fragiadaki M,Shi-wen Xu, Ponticos M, Khan K, Denton C, Garcia P, Bou-Gharios G, Yamakawa A, Morimoto C, Abraham D
    • Journal Title

      Biochemistry and Biophysics Reports

      Volume: 7 Pages: 246-252

    • DOI

      10.1016/j.bbrep.2016.06.022

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomains2016

    • Author(s)
      Nomura, S. Iwata, S. Hatano, R. Komiya, E. Dang, N. H. Iwao, N. Ohnuma, K. Morimoto, C.
    • Journal Title

      Biochem Biophys Res Commun

      Volume: 474 Issue: 1 Pages: 111-7

    • DOI

      10.1016/j.bbrc.2016.04.081

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research / Acknowledgement Compliant
  • [Journal Article] A humanized anti-CD26 monoclonal antibody inhibits cell growth of malignant mesothelioma via retarded G2/M cell cycle transition.2016

    • Author(s)
      Hayashi M, Madokoro H, Yamada K, Nishida H, Morimoto C, Sakamoto M, Yamada T.
    • Journal Title

      Cancer Cell International

      Volume: 30 Issue: 1 Pages: 35-35

    • DOI

      10.1186/s12935-016-0310-9

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Translational research based on CD26 molecule2016

    • Author(s)
      森本幾夫
    • Journal Title

      Clinical Rheumatology and Related Research

      Volume: 28 Issue: 1 Pages: 91-94

    • DOI

      10.14961/cra.28.91

    • NAID

      130005154613

    • ISSN
      0914-8760, 2189-0595
    • Related Report
      2016 Annual Research Report
    • Peer Reviewed
  • [Journal Article] CD26抗体を基盤とするトランスレーショナルリサーチ:悪性中皮腫の新規治療法開発を目指して2016

    • Author(s)
      森本幾夫、大沼圭
    • Journal Title

      The Japanese Journal of Pediatric Hematology / Oncology

      Volume: 53 Issue: 3 Pages: 182-188

    • DOI

      10.11412/jspho.53.182

    • NAID

      130005606021

    • ISSN
      2187-011X, 2189-5384
    • Related Report
      2016 Annual Research Report
    • Peer Reviewed
  • [Journal Article] 標的別分子標的薬6)モノクローナル抗体2016

    • Author(s)
      大沼圭、森本幾夫
    • Journal Title

      腎臓内科

      Volume: 4 Pages: 52-60

    • Related Report
      2016 Annual Research Report
    • Peer Reviewed
  • [Presentation] 加齢皮膚で誘発される機械的かゆみ調節機構の解明2019

    • Author(s)
      古宮栄利子、冨永光俊、波多野良、伊藤匠、大塚春奈、本田耕太郎、外山扇雅、鎌田弥生、大沼圭、森本幾夫、髙森建二
    • Organizer
      第15回加齢皮膚医学研究会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Anti-CD26 Humanized Monoclonal Antibody Conjugated To Triptolide Inhibits Mesothelioma Cell Growth Via Transportation Into Nucleus And Impaired RNA Polymerase II2018

    • Author(s)
      Yamada T, Madokoro H, Yamada K, Nishida H, Morimoto C, Sakamoto M, Hayashi M
    • Organizer
      The 6th JCA-AACR Special Joint Conference,
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 機械的かゆみの調節メカニズムの解明2018

    • Author(s)
      古宮栄利子、波多野良、大塚春奈、伊藤匠、松田浩則、須賀康、大沼圭、冨永光俊、森本幾夫、髙森建二
    • Organizer
      第82回日本皮膚科学会東京支部
    • Related Report
      2018 Annual Research Report
  • [Presentation] Interleukin-26-targeted therapy for the control of chronic GVHD.2018

    • Author(s)
      Ryo Hatano, Haruna Otsuka, Eriko Komiya, Takumi Itoh, Noriaki Iwao, Taketo Yamada, Chikao Morimoto, KeiOhnuma.
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] CD26/DPPⅣはエンドモルフィンによる機械的かゆみを制御する2018

    • Author(s)
      古宮栄利子、波多野良、伊藤匠、松田浩則、大沼圭,森本幾夫、冨永光俊、髙森建二
    • Organizer
      第28回国際痒みシンポジウム
    • Related Report
      2018 Annual Research Report
  • [Presentation] CD26分子はDPPⅣ酵素活性によって乾癬のかゆみを調節する2018

    • Author(s)
      古宮栄利子、波多野良、大塚春奈、伊藤匠、大沼圭、冨永光俊、森本幾夫、髙森建二
    • Organizer
      第33回日本乾癬学会学術大会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 乾癬における新規炎症性サイトカインIL-26の役割と分子標的療法の開発2018

    • Author(s)
      伊藤匠、波多野良、古宮栄利子、大塚春奈、冨永光俊、髙森建二、森本幾夫、大沼圭
    • Organizer
      第33回日本乾癬学会学術大会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Anti-CD26 humanized antibody-triptolide conjugate moves into nucleus and impairs RNA polymeraseⅡ2018

    • Author(s)
      山田健人、間所裕子、西田浩子、森本幾夫、坂元亨宇、林睦
    • Organizer
      第107回日本病理学会総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 全身性エリテマトーデスのステロイド減量困難例におけるCD26陰性T細胞サブセットの増加について2018

    • Author(s)
      波多野良、大沼圭、石井智徳、伊藤匠、岩田哲史、奥村康、関川巖、森本幾夫
    • Organizer
      第62回日本リウマチ学会総会・学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 難治性自己免疫疾患における新規炎症性サイトカインIL-26の役割と分子標的療法の開発2018

    • Author(s)
      伊藤匠、波多野良、岩田哲史、大沼圭、森本幾夫
    • Organizer
      第62回日本リウマチ学会総会・学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] 急性GVHDマウスモデルにおけるHMGB1の動態に関する検討2018

    • Author(s)
      岩尾憲明、大沼圭、大塚春奈、波多野良、古宮栄利子、伊藤匠、森本幾夫
    • Organizer
      第40回日本造血細胞移植学会
    • Related Report
      2017 Annual Research Report
  • [Presentation] CD26/DPPIV regulates mechanical itch in a mechanistically distinct manner from chemical itch2017

    • Author(s)
      Eriko Komiya, Ryo Hatano, Haruna Otsuka, Takumi Itoh, Hiroto Yamazaki, Mitsutoshi Tominaga, Kenji Takamori, Kei Ohnuma, Chikao Morimoto.
    • Organizer
      第42回日本研究皮膚科学会
    • Related Report
      2017 Annual Research Report
  • [Presentation] IL-26 facilitates angiogenesis and skin inflammation via inducing FGF2 production in a murine model of imiquimod-induced psoriasis.2017

    • Author(s)
      Takumi Itoh, Ryo Hatano, Haruna Otsuka, Noriaki Iwao, Satoshi Iwata, Taketo Yamada, Chikao Morimoto.
    • Organizer
      第46回日本免疫学会
    • Related Report
      2017 Annual Research Report
  • [Presentation] The regulation of pruritus in psoriasis and atopic dermatitis-a possible role for CD26/DPPIV.2017

    • Author(s)
      Eriko Komiya, Ryo Hatano, Haruna Otsuka, Takumi Itoh, Hiroto Yamazaki, Taketo Yamada, Yasushi Suga, Utako Kimura, Mitsutoshi Tominaga, Kenji Takamori, Kei Ohnuma, Chikao Morimoto.
    • Organizer
      9th World Congress on Itch
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 全身性エリテマトーデスのステロイド治療抵抗性とCD26陰性T細胞サブセットとの関係性について.2017

    • Author(s)
      波多野良、大沼圭、石井智徳、岩田哲史、奥村康、関川巖、森本幾夫.
    • Organizer
      第61回日本リウマチ学会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Humanized anti-CD26 monoclonal antibody, YS110, has anti-myeloma efficacy for the treatment of high-risk multiple myeloma.2017

    • Author(s)
      Nishida H, Hayashi M, Morimoto C, Sakamoto M, Yamada T.
    • Organizer
      The 59th American Society of Hematology Annual Meeting and Exposition.
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Anti-CD26 humanized monoclonal antibody conjugated to triptolide is transported into nucleus and impairs RNA polymerase II.2017

    • Author(s)
      Yamada T, Madokoro H, Nishida H, Morimoto C, Sakamoto M, Hayashi M.
    • Organizer
      生命科学系学会合同年次大会(ConBio2017)
    • Related Report
      2017 Annual Research Report
  • [Presentation] Humanized anti-CD26 monoclonal antibody has a therapeutic potentiality against multiple myeloma.2017

    • Author(s)
      Nishida H, Hayashi M, Morimoto C, Sakamoto M, Yamada T.
    • Organizer
      第79回日本血液学会
    • Related Report
      2017 Annual Research Report
  • [Presentation] CD26/DPPIV-mediated regulation of pruritus in psoriasis2016

    • Author(s)
      Eriko Komiya
    • Organizer
      研究皮膚科学会 第41回年次学術大会・総会
    • Place of Presentation
      仙台国際会議場
    • Year and Date
      2016-11-11
    • Related Report
      2016 Annual Research Report
    • Int'l Joint Research
  • [Presentation] CD26の機能と治療応2016

    • Author(s)
      森本幾夫
    • Organizer
      中皮腫シンポジウム
    • Place of Presentation
      兵庫医科大学
    • Year and Date
      2016-10-29
    • Related Report
      2016 Annual Research Report
    • Invited
  • [Presentation] 乾癬においてCD26/DPPIVはsubstance Pの切断を促進してかゆみを調節する2016

    • Author(s)
      古宮栄利子
    • Organizer
      第31回日本乾癬学会学術大会
    • Place of Presentation
      ホテル東日本宇都宮
    • Year and Date
      2016-09-02
    • Related Report
      2016 Annual Research Report
  • [Presentation] CD26陽性T細胞サブセットに基づく全身性エリテマトーデスの病態解析2016

    • Author(s)
      波多野良
    • Organizer
      第60回日本リウマチ学会
    • Place of Presentation
      横浜(会場:パシフィコ横浜)
    • Year and Date
      2016-04-22
    • Related Report
      2016 Annual Research Report
  • [Book] Advances in Medicine and Biology2018

    • Author(s)
      Hatano R, Ohnuma K, Yamada T, Okamoto T, Komiya E, Otsuka H, Itoh T, Yamazaki H, Iwao N, Kaneko Y, Dang NH, Morimoto C.
    • Total Pages
      45
    • Publisher
      Nova Science Publishers, Inc.
    • Related Report
      2018 Annual Research Report 2017 Annual Research Report
  • [Book] Horizons in Cancer Research2017

    • Author(s)
      Ohnuma K, Hatano R, Yamazaki H, Kaneko Y, Dang NH, Morimoto C.
    • Total Pages
      33
    • Publisher
      Nova Science Publishers, Inc.
    • Related Report
      2017 Annual Research Report
  • [Book] A New Horizon in Malignant Pleural Mesothelioma Management, Horizons in Cancer Researc2016

    • Author(s)
      Ohnuma K, Hatano R, Yamazaki H, KanekoY, Dang NH, Morimoto C1.Ohnuma K, Hatano R, Yamazaki H, KanekoY, Dang NH, Morimoto C
    • Total Pages
      220
    • Publisher
      Nova Science Publishers,Inc
    • Related Report
      2016 Annual Research Report
  • [Remarks] 順天堂大学大学院医学研究科 免疫病・がん先端治療学講座ホームページ

    • URL

      https://www.juntendo.ac.jp/graduate/laboratory/labo/immunity_cancer/

    • Related Report
      2018 Annual Research Report
  • [Patent(Industrial Property Rights)] 免疫チェックポイント阻害剤2019

    • Inventor(s)
      大沼圭、森本幾夫、波多野良
    • Industrial Property Rights Holder
      学校法人順天堂
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2019-004480
    • Filing Date
      2019
    • Related Report
      2018 Annual Research Report
  • [Patent(Industrial Property Rights)] 抗ヒトCD26モノクローナル抗体2018

    • Inventor(s)
      森本幾夫、波多野良、山田健人、大沼圭
    • Industrial Property Rights Holder
      学校法人順天堂,学校法人埼玉医科大学
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2018-049308
    • Filing Date
      2018
    • Related Report
      2018 Annual Research Report 2017 Annual Research Report
  • [Patent(Industrial Property Rights)] 抗ヒトIL-26抗体2017

    • Inventor(s)
      森本幾夫、波多野良、大沼圭、伊藤匠
    • Industrial Property Rights Holder
      学校法人順天堂
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2017-231439
    • Filing Date
      2017
    • Related Report
      2017 Annual Research Report

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi